These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 637625)

  • 1. delta9-Tetrahydrocannabinol: tolerance after noncontingent exposure in rats.
    Järbe TU
    Arch Int Pharmacodyn Ther; 1978 Jan; 231(1):49-56. PubMed ID: 637625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance development to the effect of delta9-tetrahydrocannabinol on conditioned behavior: role of treatment interval and influence of microsomal metabolism.
    Davis WM; Borgen LA
    Arch Int Pharmacodyn Ther; 1975 Jan; 213(1):97-112. PubMed ID: 1156021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance to the effects of delta9-THC on shuttle-box performance and body temperature.
    ten Ham M
    Pharmacol Biochem Behav; 1977 Feb; 6(2):183-5. PubMed ID: 859896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of delta9-thc induced hypothermia in rats.
    Schmeling WT; Hosko MJ
    Arch Int Pharmacodyn Ther; 1977 Jun; 227(2):302-8. PubMed ID: 907415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive effects of delta9-tetrahydrocannabinol.
    Kosersky DS
    Arch Int Pharmacodyn Ther; 1978 May; 233(1):76-81. PubMed ID: 686909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profound hypothermia in mammals treated with tetrahydrocannabinols, morphine, or chlorpromazine.
    Haavik CO
    Fed Proc; 1977 Nov; 36(12):2595-8. PubMed ID: 913617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of delta 9-tetrahydrocannabinol-induced tolerance by specific kinase inhibitors.
    Bass CE; Welch SP; Martin BR
    Eur J Pharmacol; 2004 Aug; 496(1-3):99-108. PubMed ID: 15288581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and subchronic influences of tetrahydrocannabinols on water and food intake, body weight, and temperature in rats.
    Johansson JO; Jarbe TU; Henriksson BG
    TIT J Life Sci; 1975; 5(1-2):17-27. PubMed ID: 1188935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance to the cardiovascular effects of delta9-tetrahydrocannabinol in the rat.
    Adams MD; Chait LD; Earnhardt JT
    Br J Pharmacol; 1976 Jan; 56(1):43-8. PubMed ID: 1252665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic treatment with Delta(9)-tetrahydrocannabinol impairs spatial memory and reduces zif268 expression in the mouse forebrain.
    Boucher AA; Vivier L; Metna-Laurent M; Brayda-Bruno L; Mons N; Arnold JC; Micheau J
    Behav Pharmacol; 2009 Feb; 20(1):45-55. PubMed ID: 19179850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic mapping of the time-dependent effects of delta 9-tetrahydrocannabinol administration in the rat.
    Whitlow CT; Freedland CS; Porrino LJ
    Psychopharmacology (Berl); 2002 May; 161(2):129-36. PubMed ID: 11981592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzodiazepine-like behavioral effects following withdrawal from chronic delta-9-tetrahydrocannabinol administration in rats.
    Holson RR; Ali SF; Scallet AC; Slikker W; Paule MG
    Neurotoxicology; 1989; 10(3):605-19. PubMed ID: 2576305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance to the reinforcing effects of morphine in delta9-tetrahydrocannabinol treated mice.
    Jardinaud F; Roques BP; Noble F
    Behav Brain Res; 2006 Oct; 173(2):255-61. PubMed ID: 16884789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing the selectivity of the discriminative stimulus effects of delta 9-tetrahydrocannabinol: complete substitution with methanandamide.
    Alici T; Appel JB
    Pharmacol Biochem Behav; 2004 Nov; 79(3):431-7. PubMed ID: 15582014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute delta9-tetrahydrocannabinol exposure facilitates quinpirole-induced hyperlocomotion.
    Gorriti MA; Ferrer B; del Arco I; Bermúdez-Silva FJ; de Diego Y; Fernandez-Espejo E; Navarro M; Rodríguez de Fonseca F
    Pharmacol Biochem Behav; 2005 May; 81(1):71-7. PubMed ID: 15894066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analgesic, heart rate, and temperature effects of delta8-THC during acute and chronic administration to conscious rats.
    Hine B; Toreelio M; Gershon S
    Pharmacology; 1977; 15(1):63-72. PubMed ID: 14347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between the in vivo and an in vitro expression of opiate withdrawal precipitated by naloxone: their antagonism by l-(-)-delta9-tetrahydrocannabinol.
    Frederickson RC; Hewes CR; Aiken JW
    J Pharmacol Exp Ther; 1976 Nov; 199(2):375-84. PubMed ID: 988178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similarities between delta9-tetrahydrocannabinol (delta9-THC) and reserpine-like drugs.
    Carder B; Deikel SM
    Behav Biol; 1976 Jul; 17(3):313-32. PubMed ID: 971187
    [No Abstract]   [Full Text] [Related]  

  • 19. Tolerance to the effect of delta9-tetrahydrocannabinol in mice on intestinal motility, temperature and locomotor activity.
    Anderson PF; Jackson DM; Chesher GB; Malor R
    Psychopharmacologia; 1975 Jul; 43(1):31-6. PubMed ID: 1161992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of delta9-tetrahydrocannabinol with d-amphetamine, cocaine, and nicotine in rats.
    Pryor GT; Larsen FF; Husain S; Braude MC
    Pharmacol Biochem Behav; 1978 Mar; 8(3):295-318. PubMed ID: 652837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.